Gunaratne, Ruwan <br/><br/>
Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass.  [electronic resource] 

 -  Nature biotechnology  08 2018 
 - 606-613 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1546-1696 
<br/><br/><label>Standard No.: </label>10.1038/nbt.4153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--administration & dosage<br/>Aptamers, Nucleotide--administration & dosage<br/>Cardiopulmonary Bypass--adverse effects<br/>Crystallography, X-Ray<br/>Drug Combinations<br/>Factor Xa--chemistry<br/>Factor Xa Inhibitors--administration & dosage<br/>Heparin--adverse effects<br/>Humans<br/>Postoperative Hemorrhage--drug therapy<br/>Protein Conformation--drug effects